Effect of milk peptides on higher central nervous system in elderly persons.
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000019265
- Lead Sponsor
- Tokyo Denki University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 14
Not provided
1) Subjects with MMSE test score less than 24. 2) Subjects with diagnosis of dementia by cerebrovascular disease or Alzheimer's disease. 3) Subjects with heart disease. 4) Subjects who had heart attack or cerebral stroke within 6 months. 5) Subjects with acute hepatic dysfunction or active phase of chronic viral hepatitis. 6) Diabetic patients with retinopathy or nephropathy or history of hypoglycemic attack or blood glucose more than 200mg/dl. 7) Subjects with systolic blood pressure more than 180mmHg or diastolic blood pressure more than 110mmHg. 8) Subjects with acute orthopedic pain or neurologic manifestation. 9) Subjects with osteoporosis and history of compression fracture. 10) Subjects with milk allergy. 11) Subjects who use regularly supplements that may influence cerebral function; e.g. DHA, EPA, Catechin. 12) Patients who are judged inappropriate for the study by the physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reaction time of task-switching test
- Secondary Outcome Measures
Name Time Method Correct answer ratio of task Functional MRI Structural change of higher central nervous system